HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dramatic efficacy of low dose lenalidomide as single agent in a patient with refractory gastric non-human immunodeficiency virus-associated plasmablastic lymphoma.

AuthorsSylvain Carras, Caroline Regny, Michel Peoc'h, Julie Gervasoni, Remy Gressin, Jean-Yves Cahn, Lysiane Molina
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 56 Issue 10 Pg. 2986-8 ( 2015) ISSN: 1029-2403 [Electronic] United States
PMID25676034 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide
Topics
  • Aged, 80 and over
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Humans
  • Lenalidomide
  • Male
  • Plasmablastic Lymphoma (diagnosis, drug therapy, surgery)
  • Retreatment
  • Stomach Neoplasms (diagnosis, drug therapy, surgery)
  • Thalidomide (administration & dosage, analogs & derivatives)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: